Product Description
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body.
The Transdermal Drug Patches market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Transdermal Drug Patches market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Transdermal Drug Patches Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Transdermal Drug Patches market are:
Nitto Denko Corporation
Endo International
NAL Pharmaceutical Group Limited
Mylan N.V.
Johnson & Johnson
GlaxoSmithKline
Boehringer Ingelheim
UCB
Hisamitsu Pharmaceutical Co., Inc.
Novartis International AG
Teikoku Seiyaku
LTS Lohmann Therapie-Systeme AG
Most important types of Transdermal Drug Patches products covered in this report are:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Most widely used downstream fields of Transdermal Drug Patches market covered in this report are:
Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.